Phase <scp>II</scp> clinical trial of pazopanib for patients with unresectable or metastatic malignant peripheral nerve sheath tumors
Yoshihiro Nishida(Nagoya University), Akira Kawai(GTx (United States)), Shunji Takahashi(Japanese Foundation For Cancer Research), Hiroaki Hiraga, Hiroshi Urakawa(Nagoya University Hospital), Hiroyuki Tsuchiya(Kanazawa University), Takafumi Ueda(The University of Osaka), Robert Nakayama(Keio University), Shunsuke Hamada(Aichi Cancer Center), Masahiko Ando(Nagoya University Hospital), Yachiyo Kuwatsuka(Nagoya University Hospital), Yoshihiro Matsumoto(Jikei University Kashiwa hospital), Takahiro Goto(Tokyo Metropolitan Komagome Hospital), Yuichi Ando(Nagoya University Hospital), Keisuke Ae, Toshifumi Ozaki(Okayama University), Norifumi Naka(University of the Witwatersrand), Eisuke Kobayashi
Cited by 25
Related Papers
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
|Annals of Oncology|2021|978
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2021|558
Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2021|453
Osteosarcoma of the Pelvis: Experience of the Cooperative Osteosarcoma Study Group
|Journal of Clinical Oncology|2003|343